Tapewire

NYSE · USD

SMHI

SEACOR Marine Holdings Inc.

Export transactions ↓
Tapewire entity
6091
SEC CIK
0001690334
Parsed reports
282

Last 12 months

Inside the activity.

0 purchase rows · 32 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202608
Jul 2026011
Aug 2026010
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 12, 2023 Filed Sep 13, 2023 21:24 UTC SaleCommon Stock 13,236 $14.03 $185,701.08
Disclosure

SEC source: 0001209191-23-049309 · doc4.xml · nonDerivative · entry 2

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 189,437

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.9974 to $14.1173, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F3 · ownership.direct: The reported sale of 13,236 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2022.

Read SEC document
September 12, 2023 Filed Sep 13, 2023 21:22 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 15,872 $14.03 $222,684.16
Disclosure

SEC source: 0001209191-23-049308 · doc4.xml · nonDerivative · entry 2

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 389,422

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.9985 to $14.1221, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F3 · ownership.direct: The reported sale of 15,872 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
September 11, 2023 Filed Sep 13, 2023 21:24 UTC SaleCommon Stock 602 $14.00 $8,428.00
Disclosure

SEC source: 0001209191-23-049309 · doc4.xml · nonDerivative · entry 1

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 202,673

F1 · ownership.direct: The reported sale of 602 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2022.

Read SEC document
September 11, 2023 Filed Sep 13, 2023 21:22 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 899 $14.00 $12,586.00
Disclosure

SEC source: 0001209191-23-049308 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 405,294

F1 · ownership.direct: The reported sale of 899 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
September 07, 2023 Filed Sep 7, 2023 20:53 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 1,770 $13.08 $23,151.60
Disclosure

SEC source: 0001209191-23-048655 · doc4.xml · nonDerivative · entry 3

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 406,193

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F6 · ownership.direct: The reported sale of 1,770 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
September 06, 2023 Filed Sep 7, 2023 20:53 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 2,543 $13.02 $33,109.86
Disclosure

SEC source: 0001209191-23-048655 · doc4.xml · nonDerivative · entry 2

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 407,963

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F4 · ownership.direct: The reported sale of 2,543 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
September 05, 2023 Filed Sep 7, 2023 20:53 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 5,687 $13.01 $73,987.87
Disclosure

SEC source: 0001209191-23-048655 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 410,506

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · ownership.direct: The reported sale of 5,687 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
July 24, 2023 Filed Jul 25, 2023 20:33 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 2,392 $12.09 $28,919.28
Disclosure

SEC source: 0001209191-23-043312 · doc4.xml · nonDerivative · entry 2

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 416,193

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F4 · ownership.direct: The reported sale of 2,392 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
July 21, 2023 Filed Jul 25, 2023 20:33 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 3,511 $12.00 $42,132.00
Disclosure

SEC source: 0001209191-23-043312 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 418,585

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F2 · ownership.direct: The reported sale of 3,511 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
July 19, 2023 Filed Jul 20, 2023 20:42 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 700 $12.00 $8,400.00
Disclosure

SEC source: 0001209191-23-042907 · doc4.xml · nonDerivative · entry 2

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,096

F2 · ownership.direct: The reported sale of 700 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:42 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 328 $12.00 $3,936.00
Disclosure

SEC source: 0001209191-23-042907 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,796

F1 · ownership.direct: The reported sale of 328 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 21:22 UTC
Llorca JesusEVP & CFO
SaleCommon Stock 3,069 $12.01 $36,847.95
Disclosure

SEC source: 0001209191-23-042466 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 423,124

F1 · ownership.direct: The reported sale of 3,069 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 9, 2022.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 20:28 UTC Tax withholdingCommon Stock 3,266 $9.74 $31,810.84
Disclosure

SEC source: 0001209191-23-035399 · doc4.xml · nonDerivative · entry 2

Miguel Bejos Alfredo · CIK 0001777507 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,119

Read SEC document
June 06, 2023 Filed Jun 7, 2023 23:41 UTC GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035244 · doc4.xml · nonDerivative · entry 1

Persily Julie · CIK 0001593007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,852

F1 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 23:39 UTC GrantCommon Stock 20,174 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035242 · doc4.xml · nonDerivative · entry 1

MORSE ANDREW R · CIK 0001254946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,640

F1 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 23:37 UTC GrantCommon Stock 15,852 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035240 · doc4.xml · nonDerivative · entry 2

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,874

F2 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:28 UTC GrantCommon Stock 10,912 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035399 · doc4.xml · nonDerivative · entry 1

Miguel Bejos Alfredo · CIK 0001777507 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,385

F1 · shares: The restricted stock award reported on this Form 4 will lapse on the earlier of (i) the date of the 2024 annual meeting of stockholders of the Issuer and (ii) June 6, 2024.

Read SEC document
June 05, 2023 Filed Jun 7, 2023 23:37 UTC SaleCommon Stock 16,000 $9.13 $146,080.00
Disclosure

SEC source: 0001209191-23-035240 · doc4.xml · nonDerivative · entry 1

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,022

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.94 to $9.29, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Read SEC document
March 08, 2023 Filed Mar 9, 2023 21:42 UTC Tax withholdingCommon Stock 25,611 $10.29 $263,537.19
Disclosure

SEC source: 0001209191-23-017541 · doc4.xml · nonDerivative · entry 2

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,275

Read SEC document
March 08, 2023 Filed Mar 9, 2023 21:44 UTC SaleCommon Stock 21,666 $10.21 $221,209.86
Disclosure

SEC source: 0001209191-23-017544 · doc4.xml · nonDerivative · entry 1

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,022

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Read SEC document
March 08, 2023 Filed Mar 9, 2023 21:44 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
Tax withholdingCommon Stock 26,741 $10.29 $275,164.89
Disclosure

SEC source: 0001209191-23-017543 · doc4.xml · nonDerivative · entry 2

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,322

Read SEC document
March 08, 2023 Filed Mar 9, 2023 21:40 UTC
Gellert John MDirector · President and CEO
Tax withholdingCommon Stock 63,984 $10.29 $658,395.36
Disclosure

SEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 3

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 759,150

Read SEC document
March 08, 2023 Filed Mar 9, 2023 21:41 UTC
Llorca JesusEVP & CFO
Tax withholdingCommon Stock 64,194 $10.29 $660,556.26
Disclosure

SEC source: 0001209191-23-017540 · doc4.xml · nonDerivative · entry 2

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,193

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:42 UTC GrantPerformance Restricted Stock Units · Derivative 18,595 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017541 · doc4.xml · derivative · entry 3

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,595

Underlying: Common Stock · 18,595 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:42 UTC GrantCommon Stock 56,913 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017541 · doc4.xml · nonDerivative · entry 1

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,886

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:44 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantPerformance Restricted Stock Units · Derivative 19,920 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017543 · doc4.xml · derivative · entry 3

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,920

Underlying: Common Stock · 19,920 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:44 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantCommon Stock 60,978 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017543 · doc4.xml · nonDerivative · entry 1

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,063

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:40 UTC
Gellert John MDirector · President and CEO
GrantPerformance Restricted Stock Units · Derivative 47,810 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017539 · doc4.xml · derivative · entry 8

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,810

Underlying: Common Stock · 47,810 shares

Expires not disclosed

F6 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F7 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

F7 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:40 UTC
Gellert John MDirector · President and CEO
GrantCommon Stock 146,343 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 2

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 823,134

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:41 UTC
Llorca JesusEVP & CFO
GrantPerformance Restricted Stock Units · Derivative 38,515 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017540 · doc4.xml · derivative · entry 3

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,515

Underlying: Common Stock · 38,515 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $11.61, $13.21, $14.91, $16.62 and $18.22, respectively.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 21:41 UTC
Llorca JesusEVP & CFO
GrantCommon Stock 117,888 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017540 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 490,387

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2024 and ending on March 4, 2026.

Read SEC document
March 07, 2023 Filed Feb 13, 2024 23:44 UTC
Gellert John MDirector · President and CEO
GiftCommon Stock 12,634 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-014785 · ownership.xml · nonDerivative · entry 2

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · MCG Assets, LLC

Disclosed balance after: 0

F2 · kind: On 3/7/23, MCG Assets, LLC contributed 12,634 shares to a grantor retained annuity trust ("GRAT"). The GRAT has an independent trustee and the Reporting Person has no investment control thereof. Accordingly, shares owned by the GRAT are not reported by the Reporting Person. The terms of the GRAT provide for two annual annuity payments to MCG Assets, LLC and, upon expiration of the GRAT, the Reporting Person is a co-beneficiary of the remainder (if any) of the GRAT.

F1 · ownership.nature: The Reporting Person serves as a manager of MCG Assets, LLC and, as such, has the power to direct the voting and disposition of the reported securities. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the reported securities.

Read SEC document
March 01, 2023 Filed Feb 13, 2024 23:44 UTC
Gellert John MDirector · President and CEO
GiftCommon Stock 4,100 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-014785 · ownership.xml · nonDerivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · MCG Assets, LLC

Disclosed balance after: 12,634

F1 · ownership.nature: The Reporting Person serves as a manager of MCG Assets, LLC and, as such, has the power to direct the voting and disposition of the reported securities. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the reported securities.

Read SEC document
February 23, 2023 Filed Mar 9, 2023 21:40 UTC
Gellert John MDirector · President and CEO
GiftCommon Stock 8,534 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 4

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · MCG Assets, LLC

Disclosed balance after: 8,534

F2 · ownership.nature: The Reporting Person serves as the manager of MCG Assets, LLC and, as such, has the power to direct the voting and disposition of the reported securities. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest in the securities.

Read SEC document
February 23, 2023 Filed Mar 9, 2023 21:40 UTC
Gellert John MDirector · President and CEO
GiftCommon Stock 6,234 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-017539 · doc4.xml · nonDerivative · entry 1

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 676,791

Read SEC document
June 09, 2022 Filed Jun 9, 2022 21:56 UTC GrantCommon Stock 10,885 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035547 · doc4.xml · nonDerivative · entry 2

Miguel Bejos Alfredo · CIK 0001777507 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,473

F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023.

Read SEC document
June 09, 2022 Filed Jun 9, 2022 21:57 UTC GrantCommon Stock 20,124 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035553 · doc4.xml · nonDerivative · entry 1

MORSE ANDREW R · CIK 0001254946 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,466

F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023.

Read SEC document
June 09, 2022 Filed Jun 9, 2022 21:53 UTC GrantCommon Stock 13,965 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035542 · doc4.xml · nonDerivative · entry 1

Persily Julie · CIK 0001593007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,852

F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023.

Read SEC document
June 09, 2022 Filed Jun 9, 2022 21:52 UTC GrantCommon Stock 15,813 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035537 · doc4.xml · nonDerivative · entry 1

Regan Robert Christopher · CIK 0001338856 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,688

F1 · shares: The restricted stock award reported on this Form 4 will lapse on June 7, 2023.

Read SEC document
June 08, 2022 Filed Jun 9, 2022 21:56 UTC Tax withholdingCommon Stock 6,500 $9.18 $59,670.00
Disclosure

SEC source: 0001209191-22-035547 · doc4.xml · nonDerivative · entry 1

Miguel Bejos Alfredo · CIK 0001777507 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,588

Read SEC document
March 11, 2022 Filed Mar 15, 2022 22:59 UTC GrantPerformance Restricted Stock Units · Derivative 20,080 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-018968 · doc4.xml · derivative · entry 3

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,080

Underlying: Common Stock · 20,080 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 22:59 UTC GrantCommon Stock 72,291 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-018968 · doc4.xml · nonDerivative · entry 2

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,973

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2023 and ending on March 4, 2025.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 22:59 UTC Tax withholdingCommon Stock 9,840 $5.88 $57,859.20
Disclosure

SEC source: 0001209191-22-018968 · doc4.xml · nonDerivative · entry 1

Rossmiller Gregory Scott · CIK 0001737606 · SVP & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,682

Read SEC document
March 11, 2022 Filed Mar 15, 2022 23:02 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantPerformance Restricted Stock Units · Derivative 20,080 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-018970 · doc4.xml · derivative · entry 3

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,080

Underlying: Common Stock · 20,080 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 23:02 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
GrantCommon Stock 72,291 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-018970 · doc4.xml · nonDerivative · entry 2

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,085

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2023 and ending on March 4, 2025.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 23:02 UTC
Everett Andrew H IISr. VP, General Counsel & Secy
Tax withholdingCommon Stock 13,305 $5.88 $78,233.40
Disclosure

SEC source: 0001209191-22-018970 · doc4.xml · nonDerivative · entry 1

Everett Andrew H II · CIK 0001728923 · Sr. VP, General Counsel & Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,794

Read SEC document
March 11, 2022 Filed Mar 15, 2022 22:54 UTC
Llorca JesusEVP & CFO
GrantPerformance Restricted Stock Units · Derivative 45,515 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-018967 · doc4.xml · derivative · entry 3

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,515

Underlying: Common Stock · 45,515 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F3 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

F3 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 22:54 UTC
Llorca JesusEVP & CFO
GrantCommon Stock 163,857 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-018967 · doc4.xml · nonDerivative · entry 2

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,499

F1 · shares: The restricted stock award reported on this Form 4 will lapse in three equal annual installments beginning on March 4, 2023 and ending on March 4, 2025.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 22:54 UTC
Llorca JesusEVP & CFO
Tax withholdingCommon Stock 38,214 $5.88 $224,698.32
Disclosure

SEC source: 0001209191-22-018967 · doc4.xml · nonDerivative · entry 1

Llorca Jesus · CIK 0001705427 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,642

Read SEC document
March 11, 2022 Filed Mar 15, 2022 23:04 UTC
Gellert John MDirector · President and CEO
GrantPerformance Restricted Stock Units · Derivative 58,905 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-018971 · doc4.xml · derivative · entry 7

Gellert John M · CIK 0001292966 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,905

Underlying: Common Stock · 58,905 shares

Expires not disclosed

F5 · derivative.exercise_price: Each Performance Restricted Stock Unit (each, a "PRSU") represents a contingent right to receive, at vesting, one share of Common Stock subject to the achievement of certain performance goals and service-based vesting requirements.

F6 · derivative.exercise_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

F6 · derivative.expiration_date: These PRSUs consist of five equal tranches, each of which will be earned if and when the closing price of one share of Common Stock equals or exceeds the specified stock price performance goal for such tranche for 60 consecutive trading days during the three year performance period beginning on the grant date, provided that any earned PRSUs will not be settled until the third anniversary of the grant date, subject to satisfaction of the service-based vesting requirements set forth in the award agreement. The specified stock price performance goals for each tranche are $5.02, $5.72, $6.45, $7.19 and $7.88, respectively.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.